🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2 study to evaluate the safety, and efficacy of IBI363 as N...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-02-04
Trial ID
NCT07402070
Treatments Being Tested
This study is for patients with advanced or metastatic gastric cancer whose...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-03
Trial ID
NCT07361991
Treatments Being Tested
This is a Phase 1, open-label, multicenter, dose-escalation study designed ...
Status
Active Not Recruiting
Location
Kate.Wilkinson1@health.nsw.gov.au
Start Date
2022-08-22
Trial ID
NCT05290597
Treatments Being Tested
This is a Phase II, open-label, randomized, multi-center study to assess th...
Status
Recruiting
Location
First Affiliated Hospital of Anhui Medical University
Start Date
2025-02-24
Trial ID
NCT06797297
Treatments Being Tested
This is a Phase 2, open-label, multicenter study designed to evaluate the e...
Status
Recruiting
Location
University of California, San Francisco (UCSF)
Start Date
2024-04-08
Trial ID
NCT06281678
Treatments Being Tested
Colorectal cancer (CRC) ranks as the fifth most common malignant tumor in t...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing
Start Date
2024-12-02
Trial ID
NCT06946745
Treatments Being Tested
This study is a single-arm, phase II clinical trial evaluating the safety a...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2026-01-07
Trial ID
NCT07408635
Treatments Being Tested
The study is a prospective multi-cohort clinical study. The study is divide...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2023-12-25
Trial ID
NCT06081907
Exploring the efficacy of PD-1 inhibitor combination therapy strategies for...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-09-30
Trial ID
NCT06620822
Treatments Being Tested
This is a phase 1b study designed to evaluate the safety, tolerability and ...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2024-10-15
Trial ID
NCT06610799
Treatments Being Tested